Aytu Biopharma (AYTU) Research & Development (2016 - 2025)
Historic Research & Development for Aytu Biopharma (AYTU) over the last 12 years, with Q2 2025 value amounting to $216000.0.
- Aytu Biopharma's Research & Development fell 7927.06% to $216000.0 in Q2 2025 from the same period last year, while for Dec 2025 it was $378000.0, marking a year-over-year decrease of 8546.71%. This contributed to the annual value of $1.3 million for FY2025, which is 5211.27% down from last year.
- Latest data reveals that Aytu Biopharma reported Research & Development of $216000.0 as of Q2 2025, which was down 7927.06% from $162000.0 recorded in Q1 2025.
- Aytu Biopharma's Research & Development's 5-year high stood at $4.8 million during Q2 2021, with a 5-year trough of $162000.0 in Q1 2025.
- Over the past 5 years, Aytu Biopharma's median Research & Development value was $733500.0 (recorded in 2023), while the average stood at $1.4 million.
- Per our database at Business Quant, Aytu Biopharma's Research & Development skyrocketed by 146468.53% in 2021 and then tumbled by 8570.55% in 2023.
- Aytu Biopharma's Research & Development (Quarter) stood at $4.5 million in 2021, then tumbled by 61.79% to $1.7 million in 2022, then tumbled by 69.53% to $521000.0 in 2023, then rose by 0.19% to $522000.0 in 2024, then plummeted by 58.62% to $216000.0 in 2025.
- Its Research & Development was $216000.0 in Q2 2025, compared to $162000.0 in Q1 2025 and $522000.0 in Q4 2024.